05 Nov2019
22 Oct2019
SQZ Biotech Announces Clearance of US IND Application for First Clinical Trial
First program advancing into the clinic through the SQZ-Roche collaboration in APCs for oncology
WATERTOWN, Mass., Oct. 22, 2019 (GLOBE NEWSWIRE) — SQZ Biotechnologies (SQZ), a cell therapy company developing innovative treatments for multiple therapeutic areas, today announced that the company’s Investigational New Drug (IND) application for SQZ-PBMC-HPV, a novel cellular immunotherapy of antigen presenting cells (APCs) has been cleared after submission to the U.S. Food and Drug Administration (FDA).
21 Oct2019
Verseau Launches with $50 Million to Develop First-in-Class Macrophage-Targeted Immunotherapies and Appoints George Golumbeski as Chairman of the Board
BEDFORD Mass., October 21, 2019 — Verseau Therapeutics, Inc. (“Verseau”) launched today with $50 million in financing from 20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners Ltd., The Mark Foundation for Cancer Research and Yonghua Capital.
08 Aug2019
Corindus Vascular Robotics Announces Definitive Agreement to be Acquired by Siemens Healthineers
WALTHAM, Mass., — August 8, 2019 — Corindus Vascular Robotics, Inc. [NYSE American: CVRS], a leading developer of precision vascular robotics, today announced that it has entered into a definitive merger agreement to be acquired by Siemens Healthineers AG. Under the terms of the merger agreement, Siemens Medical Solutions, a wholly-owned subsidiary of Siemens Healthineers AG, a German stock listed company, will acquire all issued and outstanding shares of common stock of Corindus for $4.28 per share in cash, representing an aggregate purchase price of approximately $1.1 billion.
26 Feb2019
Hillel Bachrach Serves as Moderator at MIT Sloan School of Management Innovation Panel
Big Data, Digitalization, and Disruption: How are the headline trends of new technology and therapeutic innovation changing how we address today’s biggest healthcare challenges?HITInfrastructure.com covers the event:
Digital Health Technology Needs to Fit into the Clinical Workflow
The biggest question when it come to digital health technology is not getting “new, cool stuff” into the hospital, but how can it fit seamlessly into the existing clinical workflow, observed Jaydeo Kinikar, head of marketing and business development at Philips Connected Care Sensing.